{"application": "software-mentions", "version": "0.8.0", "date": "2024-03-21T09:54+0000", "md5": "CBC8D60BE21752C37E0C6A9C4B1D35B5", "mentions": [{"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 0, "offsetEnd": 7}, "context": "SimulAD is a computational disease progression model (DPM) originally developed on the ADNI database to simulate the evolution of clinical and imaging markers characteristic of AD, and to quantify the disease severity (DS) of a subject.", "mentionContextAttributes": {"used": {"value": false, "score": 0.00019401311874389648}, "created": {"value": true, "score": 0.6549148559570312}, "shared": {"value": false, "score": 3.5762786865234375e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 0, "offsetEnd": 7}, "context": "SimulAD is based on the hypothesis that AD evolution can be mathematically modelled by a set of key biomarkers following a dynamical system.", "mentionContextAttributes": {"used": {"value": false, "score": 9.09566879272461e-05}, "created": {"value": false, "score": 0.0030915141105651855}, "shared": {"value": false, "score": 3.5762786865234375e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 0, "offsetEnd": 7}, "context": "SimulAD could be extended in the future to account for multiple risk factors, such as the presence of APOE4 (Kim et al. 2009), thus leading to a higher level of personalization of the predictions.", "mentionContextAttributes": {"used": {"value": false, "score": 0.005268454551696777}, "created": {"value": false, "score": 1.71661376953125e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 0, "offsetEnd": 7}, "context": "SimulAD is a promising modeling tool that may enable in the future the identification of subjects for enrollment in clinical trials, or the monitoring of the efficacy of disease modifying drugs.", "mentionContextAttributes": {"used": {"value": false, "score": 0.00014293193817138672}, "created": {"value": true, "score": 0.9299228191375732}, "shared": {"value": false, "score": 5.960464477539062e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 6, "offsetEnd": 13}, "context": "While SimulAD was previously trained on the ADNI cohort, its generalization to independent datasets has not been evaluated.", "mentionContextAttributes": {"used": {"value": false, "score": 0.0017040371894836426}, "created": {"value": false, "score": 0.0001958012580871582}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 9, "offsetEnd": 16}, "context": "Finally, SimulAD enables to assess the impact of therapeutic intervention, such as anti-amyloid treatment, on cognitive outcomes depending on the intervention time (Abi Nader et al. 2021).", "mentionContextAttributes": {"used": {"value": false, "score": 2.9921531677246094e-05}, "created": {"value": false, "score": 0.0005287528038024902}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 10, "offsetEnd": 17}, "context": "Moreover, SimulAD estimates the dynamical relationships between key biomarkers at stake during AD progression, namely: amyloid deposition, glucose hypometabolism, cerebral atrophy, cognitive and behavioural decline. ", "mentionContextAttributes": {"used": {"value": false, "score": 0.0009770393371582031}, "created": {"value": false, "score": 3.457069396972656e-05}, "shared": {"value": false, "score": 4.76837158203125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 11, "offsetEnd": 18}, "context": "Currently, SimulAD is still a research software and future efforts should focus on the development of a user-friendly platform that could be deployed in clinical routine.", "mentionContextAttributes": {"used": {"value": false, "score": 0.0002072453498840332}, "created": {"value": true, "score": 0.669156014919281}, "shared": {"value": false, "score": 0.0007205605506896973}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 13, "offsetEnd": 20}, "context": "We evaluated SimulAD by conducting a series of experiments on both ADNI and GMC cohorts which aimed at demonstrating respectively the known-groups validity, the concurrent validity and the reliability of the model.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999693632125854}, "created": {"value": false, "score": 0.0008211731910705566}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 13, "offsetEnd": 20}, "context": "We note that SimulAD presents certain advantages compared to standard event-based models, as it provides a finer-grained description of the disease for both spatial and temporal scales, in which regional changes affecting the brain are modelled on a continuous long-term time span.", "mentionContextAttributes": {"used": {"value": false, "score": 3.7789344787597656e-05}, "created": {"value": false, "score": 0.003753960132598877}, "shared": {"value": false, "score": 4.76837158203125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 15, "offsetEnd": 22}, "context": "We recall that SimulAD relies on 7 neuropsychological tests (CDRSB, MMSE, ADAS11, FAQ, RAVLT learning, RAVLT immediate and RAVLT forgetting)", "mentionContextAttributes": {"used": {"value": true, "score": 0.9773134589195251}, "created": {"value": false, "score": 2.3484230041503906e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 15, "offsetEnd": 22}, "context": "We showed that SimulAD was able to differentiate subjects across clinical groups for both cohorts (Figure 3, Table 3).", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999815225601196}, "created": {"value": false, "score": 2.849102020263672e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 16, "offsetEnd": 23}, "context": "This shows that SimulAD is robust to the imputation of the clinical scores for the GMC cohort, and that despite the induced margin of error the estimated disease severity and z-scores progression are reliable.", "mentionContextAttributes": {"used": {"value": true, "score": 0.97121262550354}, "created": {"value": false, "score": 7.152557373046875e-06}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 17, "offsetEnd": 24}, "context": "Overall, even if SimulAD proved robust to these approximations, one of the main challenge highlighted in this study points to the complexity of data integration across cohorts and studies.", "mentionContextAttributes": {"used": {"value": true, "score": 0.5066556334495544}, "created": {"value": false, "score": 2.944469451904297e-05}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 20, "offsetEnd": 27}, "context": "Finally, we applied SimulAD individually on all the patients from the GMC cohort to simulate their evolution over five years.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": false, "score": 0.001558840274810791}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 21, "offsetEnd": 28}, "context": "Within this context, SimulAD (Abi Nader et al. 2021) is a recent method allowing the analysis of clinical scores and multivariate imaging data extracted from MRI and PET scans to estimate a continuous spatio-temporal model of disease progression.", "mentionContextAttributes": {"used": {"value": false, "score": 6.29425048828125e-05}, "created": {"value": false, "score": 0.0628785490989685}, "shared": {"value": false, "score": 4.76837158203125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0, "offsetStart": 8604, "offsetEnd": 8626}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 36, "offsetEnd": 43}, "context": "Supplementary Figure 1: Overview of SimulAD.", "mentionContextAttributes": {"used": {"value": false, "score": 0.005037188529968262}, "created": {"value": false, "score": 1.8596649169921875e-05}, "shared": {"value": false, "score": 3.5762786865234375e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 38, "offsetEnd": 45}, "context": "Yet, evaluating the generalization of SimulAD to independent cohorts is essential to demonstrate the reliability of the dynamics allowing to personalize the models of disease progression, as well as the validity of the approach for providing accurate disease staging.", "mentionContextAttributes": {"used": {"value": false, "score": 0.00013184547424316406}, "created": {"value": false, "score": 0.0005304217338562012}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 41, "offsetEnd": 48}, "context": "Thanks to this mathematical formulation, SimulAD can be used to simulate the progression of changes characterizing AD by considering the subjects diagnosed with AD dementia, and for whom we compute corresponding z-scores based on their baseline measures.", "mentionContextAttributes": {"used": {"value": false, "score": 0.00025206804275512695}, "created": {"value": false, "score": 0.2318362593650818}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 41, "offsetEnd": 48}, "context": "We presented a preliminary validation of SimulAD on the clinical cohort of the GMC.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9991488456726074}, "created": {"value": true, "score": 0.7644907832145691}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 44, "offsetEnd": 51}, "context": "We illustrate in Supplementary Figure 1 how SimulAD works.", "mentionContextAttributes": {"used": {"value": false, "score": 0.0001119375228881836}, "created": {"value": false, "score": 0.004747867584228516}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 48, "offsetEnd": 55}, "context": "The disease progression previously estimated by SimulAD on the ADNI database is illustrated in Supplementary Figure 2 in which we show the evolution of the z-scores and their associated imaging and clinical measures.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9915760159492493}, "created": {"value": false, "score": 1.3947486877441406e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 50, "offsetEnd": 57}, "context": "We considered the model of evolution estimated by SimulAD on the ADNI cohort as the reference progression for AD.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999597072601318}, "created": {"value": false, "score": 0.009484529495239258}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 52, "offsetEnd": 59}, "context": "Finally, this study motivates further extensions of SimulAD that would foster its adoption in clinical practice. ", "mentionContextAttributes": {"used": {"value": false, "score": 0.000899195671081543}, "created": {"value": false, "score": 0.4548887014389038}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 53, "offsetEnd": 60}, "context": "In this study, we presented a thorough assessment of SimulAD on the independent GMC clinical cohort.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9997425675392151}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 54, "offsetEnd": 61}, "context": "Overall, these results indicate general robustness of SimulAD when applied to independent cohorts characterized by different imaging acquisition protocols.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999809265136719}, "created": {"value": false, "score": 1.1920928955078125e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 56, "offsetEnd": 63}, "context": "Finally, we showed that when applied on the GMC cohort, SimulAD was able to reliably predict the evolution of the MMSE of the subjects, highlighting its potential as a tool for individual monitoring of clinical outcomes.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999805688858032}, "created": {"value": false, "score": 0.012915194034576416}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 63, "offsetEnd": 70}, "context": "The two previous experiments aimed to quantify the validity of SimulAD in terms of disease staging based on the reference progression previously simulated on the ADNI database.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9949578642845154}, "created": {"value": false, "score": 0.0005754232406616211}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 65, "offsetEnd": 72}, "context": "This study illustrates the robustness and good generalization of SimulAD, highlighting its potential for clinical and pharmaceutical studies.", "mentionContextAttributes": {"used": {"value": false, "score": 0.2643415331840515}, "created": {"value": false, "score": 0.010095059871673584}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 69, "offsetEnd": 76}, "context": "In order to demonstrate the reliability of the dynamics estimated by SimulAD, we simulated a new model of disease progression personalized to the GMC cohort.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999783039093018}, "created": {"value": false, "score": 0.03954249620437622}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 69, "offsetEnd": 76}, "context": "The results highlighted the reliability of the dynamics simulated by SimulAD for the disease key biomarkers, and showed encouraging performances in terms of disease staging on both cohorts.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999891519546509}, "created": {"value": false, "score": 2.0742416381835938e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 72, "offsetEnd": 79}, "context": "We verified the consistency and robustness of the dynamics estimated by SimulAD by simulating the evolution of clinical and imaging-derived markers based on the GMC data.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999949932098389}, "created": {"value": false, "score": 0.00023251771926879883}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 80, "offsetEnd": 87}, "context": "Within this context, we assess in this study the generalization capabilities of SimulAD.", "mentionContextAttributes": {"used": {"value": false, "score": 0.0010346174240112305}, "created": {"value": true, "score": 0.9963610768318176}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 81, "offsetEnd": 88}, "context": "In the next paragraphs, we provide details about the mathematical formulation of SimulAD.", "mentionContextAttributes": {"used": {"value": false, "score": 8.106231689453125e-05}, "created": {"value": true, "score": 0.996414303779602}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 85, "offsetEnd": 92}, "context": "We show in Figure 3 the group-wise distribution of the disease severity estimated by SimulAD for each subject in the ADNI and GMC datasets.", "mentionContextAttributes": {"used": {"value": true, "score": 0.999976634979248}, "created": {"value": false, "score": 1.0013580322265625e-05}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 85, "offsetEnd": 92}, "context": "Overall, this shows that even if we remove FDG data and the missing clinical scores, SimulAD is still able to learn a disease progression model that can accurately stage patients and differentiate between clinical groups.", "mentionContextAttributes": {"used": {"value": false, "score": 0.0009233951568603516}, "created": {"value": false, "score": 0.026524126529693604}, "shared": {"value": false, "score": 3.5762786865234375e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "PetSurfer", "normalizedForm": "PetSurfer", "offsetStart": 85, "offsetEnd": 94}, "context": "Regional amyloid load, glucose metabolism and tau burden were computed thanks to the PetSurfer software (Greve et al. 2014). ", "mentionContextAttributes": {"used": {"value": true, "score": 0.999994158744812}, "created": {"value": false, "score": 4.5299530029296875e-06}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.999994158744812}, "created": {"value": false, "score": 4.5299530029296875e-06}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "references": [{"label": "(Greve et al. 2014)", "normalizedForm": "Greve et al. 2014", "refKey": 15, "offsetStart": 14561, "offsetEnd": 14580}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 100, "offsetEnd": 107}, "context": "(iii) Evaluation of the reliability of the progression of imaging and clinical markers estimated by SimulAD.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999901056289673}, "created": {"value": false, "score": 9.655952453613281e-06}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 111, "offsetEnd": 118}, "context": "In this section, we considered the pathological progression previously estimated in (Abi Nader et al. 2021) by SimulAD as a reference trajectory, and computed the disease severity of the individuals from both cohorts based on the procedure of Section 2.3.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999896287918091}, "created": {"value": false, "score": 1.895427703857422e-05}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 111, "offsetEnd": 118}, "context": "However, in the case where imputation would be too cumbersome or impossible, we showed in this experiment that SimulAD would still provide a reliable estimation of the disease severity of patients when some data modalities are discarded.", "mentionContextAttributes": {"used": {"value": true, "score": 0.5505645275115967}, "created": {"value": false, "score": 0.00034105777740478516}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 112, "offsetEnd": 119}, "context": "Therefore, we would recommend to take advantage of the ease to include heterogeneous data in our model, and use SimulAD with as many data modalities as possible, even if this might require some pre-processing steps to impute missing data.", "mentionContextAttributes": {"used": {"value": false, "score": 0.0011089444160461426}, "created": {"value": true, "score": 0.7528768181800842}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 115, "offsetEnd": 122}, "context": "In this work, we assessed the validity of this estimated DS, as well as the generalization of the DPM, by applying SimulAD on a new cohort from the Geneva Memory Center (GMC).", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999136924743652}, "created": {"value": true, "score": 0.5646294951438904}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "wikidataId": "Q2363545", "wikipediaExternalRef": 4479709, "lang": "en", "confidence": 0.4721, "software-name": {"rawForm": "Freesurfer", "normalizedForm": "Freesurfer", "wikidataId": "Q2363545", "wikipediaExternalRef": 4479709, "lang": "en", "confidence": 0.4721, "offsetStart": 116, "offsetEnd": 146}, "context": "We derived volumes of gray matter density in a standard anatomical space by relying on the longitudinal pipeline of Freesurfer (Reuter et al. 2012). ", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999780654907227}, "created": {"value": false, "score": 0.0002009272575378418}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999852180480957}, "created": {"value": false, "score": 0.0002009272575378418}, "shared": {"value": false, "score": 4.76837158203125e-07}}}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 117, "offsetEnd": 124}, "context": "Our evaluation procedure relies on three key aspects: (i) Development of a pre-processing pipeline allowing to apply SimulAD on the GMC cohort; (ii) Assessment of SimulAD validity for individual disease staging.", "mentionContextAttributes": {"used": {"value": false, "score": 0.21244442462921143}, "created": {"value": false, "score": 0.09872323274612427}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 120, "offsetEnd": 127}, "context": "As it generally holds for statistical and machine learning models, one of the main difficulty for the generalization of SimulAD to independent cohorts lies in the challenge of accounting for potential missing data, heterogeneity due to different acquisition protocols or even data incompatibility between cohorts.", "mentionContextAttributes": {"used": {"value": false, "score": 7.390975952148438e-05}, "created": {"value": false, "score": 0.00019997358322143555}, "shared": {"value": false, "score": 5.960464477539062e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "wikidataId": "Q2363545", "wikipediaExternalRef": 4479709, "lang": "en", "confidence": 0.4721, "software-name": {"rawForm": "Freesurfer", "normalizedForm": "Freesurfer", "wikidataId": "Q2363545", "wikipediaExternalRef": 4479709, "lang": "en", "confidence": 0.4721, "offsetStart": 123, "offsetEnd": 133}, "context": "For each subject MMSE score was available and imaging-biomarkers assessment as follows: hippocampal atrophy evaluated with Freesurfer, glucose metabolism and amyloid burden computed by extracting standardized uptake value ratio in a composite mask of regions of interest (MetaROI approach (Jagust et al. 2009;Landau, Harvey, et al. 2010;Landau, Mintun, et al. 2012)).", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999852180480957}, "created": {"value": false, "score": 3.0994415283203125e-06}, "shared": {"value": false, "score": 4.76837158203125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999852180480957}, "created": {"value": false, "score": 0.0002009272575378418}, "shared": {"value": false, "score": 4.76837158203125e-07}}}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 128, "offsetEnd": 135}, "context": "In addition to comparing the disease progression models obtained on both cohorts, we proposed to demonstrate the reliability of SimulAD by evaluating its prediction abilities at the individual level.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9956492781639099}, "created": {"value": false, "score": 0.14407014846801758}, "shared": {"value": false, "score": 1.1920928955078125e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 163, "offsetEnd": 170}, "context": "Our evaluation procedure relies on three key aspects: (i) Development of a pre-processing pipeline allowing to apply SimulAD on the GMC cohort; (ii) Assessment of SimulAD validity for individual disease staging.", "mentionContextAttributes": {"used": {"value": false, "score": 0.21244442462921143}, "created": {"value": false, "score": 0.09872323274612427}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 243, "offsetEnd": 250}, "context": "We subsequently carried out a set of experiments to evaluate the validity of our approach and showed that the results obtained on the ADNI database were reproducible on the GMC cohort, outlining the robustness and generalization properties of SimulAD.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999353885650635}, "created": {"value": true, "score": 0.53440922498703}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 265, "offsetEnd": 272}, "context": "Therefore, given that the model was estimated based on a subset of the ADNI cohort without accounting for tau-PET data, the correlation between the disease severity and tau burden on an external dataset is an appreciable demonstration of the concurrent validity of SimulAD.", "mentionContextAttributes": {"used": {"value": true, "score": 0.9999591112136841}, "created": {"value": false, "score": 1.4424324035644531e-05}, "shared": {"value": false, "score": 2.384185791015625e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}, {"type": "software", "software-type": "software", "software-name": {"rawForm": "SimulAD", "normalizedForm": "SimulAD", "offsetStart": 312, "offsetEnd": 319}, "context": "Unfortunately, this cannot be done at the moment due to the choice of the method we used for approximating the missing neuro-psychological scores (k-neighbors), and also because no early-phase amyloid-PET was available to predict the corresponding FDG uptake on the sub-sample of the ADNI database used to train SimulAD.", "mentionContextAttributes": {"used": {"value": true, "score": 0.990180253982544}, "created": {"value": false, "score": 1.1205673217773438e-05}, "shared": {"value": false, "score": 3.5762786865234375e-07}}, "documentContextAttributes": {"used": {"value": true, "score": 0.9999955892562866}, "created": {"value": true, "score": 0.9996232986450195}, "shared": {"value": false, "score": 0.0007205605506896973}}, "references": [{"label": "(Abi Nader et al. 2021", "normalizedForm": "(Abi Nader et al. 2021", "refKey": 0}]}], "references": [{"refKey": 0, "tei": "<biblStruct xml:id=\"b0\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">SimulAD: a dynamical model for personalized simulation and disease staging in Alzheimer\u2019s disease</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Cl\u00e9ment</forename><surname>Abi Nader</surname></persName>\n\t\t\t<idno type=\"ORCID\">0000-0002-4542-9148</idno>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Federica</forename><surname>Ribaldi</surname></persName>\n\t\t\t<idno type=\"ORCID\">0000-0001-9208-4472</idno>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Giovanni</forename><forename type=\"middle\">B</forename><surname>Frisoni</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Valentina</forename><surname>Garibotto</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Philippe</forename><surname>Robert</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Nicholas</forename><surname>Ayache</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Marco</forename><surname>Lorenzi</surname></persName>\n\t\t</author>\n\t\t<idno type=\"DOI\">10.1016/j.neurobiolaging.2021.12.015</idno>\n\t\t<idno>2EF645308CFCFB672F0FC0C77423BD88</idno>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">Neurobiology of Aging</title>\n\t\t<title level=\"j\" type=\"abbrev\">Neurobiology of Aging</title>\n\t\t<idno type=\"ISSN\">0197-4580</idno>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">113</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"73\" to=\"83\" />\n\t\t\t<date type=\"published\" when=\"2022-05\" />\n\t\t\t<publisher>Elsevier BV</publisher>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n"}, {"refKey": 15, "tei": "<biblStruct xml:id=\"b15\">\n\t<analytic>\n\t\t<title level=\"a\" type=\"main\">Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data</title>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Douglas</forename><forename type=\"middle\">N</forename><surname>Greve</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Claus</forename><surname>Svarer</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Patrick</forename><forename type=\"middle\">M</forename><surname>Fisher</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Ling</forename><surname>Feng</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Adam</forename><forename type=\"middle\">E</forename><surname>Hansen</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">William</forename><surname>Baare</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Bruce</forename><surname>Rosen</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Bruce</forename><surname>Fischl</surname></persName>\n\t\t</author>\n\t\t<author>\n\t\t\t<persName><forename type=\"first\">Gitte</forename><forename type=\"middle\">M</forename><surname>Knudsen</surname></persName>\n\t\t</author>\n\t\t<idno type=\"DOI\">10.1016/j.neuroimage.2013.12.021</idno>\n\t</analytic>\n\t<monogr>\n\t\t<title level=\"j\">NeuroImage</title>\n\t\t<title level=\"j\" type=\"abbrev\">NeuroImage</title>\n\t\t<idno type=\"ISSN\">1053-8119</idno>\n\t\t<imprint>\n\t\t\t<biblScope unit=\"volume\">92</biblScope>\n\t\t\t<biblScope unit=\"page\" from=\"225\" to=\"236\" />\n\t\t\t<date type=\"published\" when=\"2014-05\">2014</date>\n\t\t\t<publisher>Elsevier BV</publisher>\n\t\t</imprint>\n\t</monogr>\n</biblStruct>\n"}], "runtime": 29522, "id": "a256a67eb4ab3984b59916c0a0ebf882c046b10a", "metadata": {"id": "a256a67eb4ab3984b59916c0a0ebf882c046b10a"}, "original_file_path": "../../datalake/Samuel/SV22/SV22_xml/hal-03514292.grobid.tei.xml", "file_name": "hal-03514292.grobid.tei.xml"}